160 filings
PRE 14A
OMGA
Omega Therapeutics Inc
19 Apr 24
Preliminary proxy
4:00pm
8-K
OMGA
Omega Therapeutics Inc
16 Apr 24
Departure of Directors or Certain Officers
4:20pm
10-K
2023 FY
OMGA
Omega Therapeutics Inc
Annual report
28 Mar 24
4:31pm
8-K
OMGA
Omega Therapeutics Inc
28 Mar 24
Omega Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Strategic Update
4:15pm
SC 13G/A
OMGA
Omega Therapeutics Inc
12 Feb 24
Omega Therapeutics / FMR ownership change
12:03pm
4
Thomas McCauley
9 Feb 24
Omega Therapeutics / Thomas McCauley ownership change
5:14pm
4
OMGA
Omega Therapeutics Inc
9 Feb 24
Omega Therapeutics / Mahesh Karande ownership change
5:00pm
4/A
OMGA
Omega Therapeutics Inc
9 Feb 24
Omega Therapeutics / CHRISTIAN S SCHADE ownership change
5:00pm
4
OMGA
Omega Therapeutics Inc
9 Feb 24
Omega Therapeutics / Yan Moore ownership change
4:59pm
4
OMGA
Omega Therapeutics Inc
9 Feb 24
Omega Therapeutics / Joshua Reed ownership change
4:57pm
4
OMGA
Omega Therapeutics Inc
9 Feb 24
Omega Therapeutics / CHRISTIAN S SCHADE ownership change
4:57pm
4
OMGA
Omega Therapeutics Inc
9 Feb 24
Omega Therapeutics / Ling Zeng ownership change
4:56pm
SC 13G/A
OMGA
Omega Therapeutics Inc
9 Feb 24
Omega Therapeutics / HarbourVest Partners ownership change
4:17pm
SC 13G/A
OMGA
Omega Therapeutics Inc
9 Feb 24
Omega Therapeutics / FMR ownership change
9:28am
8-K
OMGA
Omega Therapeutics Inc
5 Jan 24
Omega Therapeutics Announces Research Collaboration with Novo Nordisk to Develop a Novel Therapeutic for Obesity Management
4:00pm
8-K
OMGA
Omega Therapeutics Inc
11 Dec 23
Amendments to Articles of Incorporation or Bylaws
4:00pm
10-Q
2023 Q3
OMGA
Omega Therapeutics Inc
Quarterly report
9 Nov 23
7:03am
8-K
OMGA
Omega Therapeutics Inc
9 Nov 23
Omega Therapeutics Reports Third Quarter 2023 Financial Results and Highlights Recent Company Progress
7:03am
8-K
OMGA
Omega Therapeutics Inc
26 Sep 23
Other Events
5:29pm
8-K
OMGA
Omega Therapeutics Inc
22 Sep 23
Entry into a Material Definitive Agreement
5:10pm